
Retatrutide
CAS: 2381089-83-2
Retatrutide is a research peptide in the glp-1 / weight management category. Retatrutide is a triple hormone receptor agonist that simultaneously activates GLP-1, GIP, and glucagon (GCGR) receptors. MiPeptidos offers Retatrutide in 6 sizes with 99.4% verified purity and full analytical documentation.
How Retatrutide Works
Retatrutide is a triple hormone receptor agonist that simultaneously activates GLP-1, GIP, and glucagon (GCGR) receptors. GLP-1 and GIP agonism drive insulin secretion and appetite suppression, while glucagon receptor activation increases energy expenditure and hepatic lipid oxidation. This triple mechanism addresses multiple metabolic pathways for potentially superior weight loss and metabolic improvement over dual agonists.
Research Applications
Pricing
| Size | Per Vial | 10-Pack |
|---|---|---|
5mg | $41.95 | $305.95 |
10mg | $71.95 | $524.95 |
15mg | $98.95 | $721.95 |
20mg | $125.95 | $918.95 |
30mg | $184.95 | $1349.95 |
60mgBest Value | $329.95 | $2408.95 |
Prices shown per vial from 10-pack. Volume discounts available for 50+ vials — contact us.
HPLC Purity Analysis
Certificate of Analysis
This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every MiPeptidos order.
Reconstitution Calculator
Inject bacteriostatic water slowly along the vial wall. Gently swirl until dissolved — never shake. Store reconstituted solution at 2-8°C and use within 30 days.
Download Product Brochure
Get our detailed Retatrutide product brochure with specifications, research applications, HPLC analysis data, and reconstitution guide. Available in English and Spanish.
Researcher Reviews
Frequently Asked Questions
Specifications
Sequence
39-amino acid peptide derived from GIP backbone; contains Aib at positions 2 and 20, alpha-methyl-Leu at position 13, and C20 fatty diacid conjugation at Lys17 via linker
Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Related Peptides

Semaglutide
A glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for glycemic control. Widely studied for its role in appetite regulation and metabolic research.

Tirzepatide
A dual GIP/GLP-1 receptor agonist studied for its effects on glucose metabolism and body weight regulation. One of the most researched peptides in the incretin class.

Liraglutide
A GLP-1 receptor agonist with an extended half-life due to fatty acid acylation. Extensively studied for glucose homeostasis and appetite signaling research.

Cagrilintide
A long-acting amylin analog researched for its effects on satiety signaling and energy balance. Often studied alongside GLP-1 agonists in combination protocols.